Please use this identifier to cite or link to this item: https://doi.org/10.1371/journal.pone.0164849
DC FieldValue
dc.titleRecurrence of Dupuytren's contracture: A consensus-based definition
dc.contributor.authorKan H.J.
dc.contributor.authorVerrijp F.W.
dc.contributor.authorHovius S.E.R.
dc.contributor.authorVan Nieuwenhoven C.A.
dc.contributor.authorSelles R.W.
dc.contributor.authorAmadio P.C.
dc.contributor.authorDegreef I.
dc.contributor.authorDenkler K.
dc.contributor.authorDias J.
dc.contributor.authorEaton C.
dc.contributor.authorGoldfarb C.A.
dc.contributor.authorHentz V.
dc.contributor.authorE Horch R.
dc.contributor.authorHurst L.
dc.contributor.authorJerosch-Herold C.
dc.contributor.authorKhouri R.K.
dc.contributor.authorLalonde D.
dc.contributor.authorLeclercq C.
dc.contributor.authorMcGrouther D.A.
dc.contributor.authorNanchahal J.
dc.contributor.authorPelissier P.
dc.contributor.authorTonkin M.
dc.contributor.authorWerker P.M.N.
dc.contributor.authorWilbrand S.
dc.contributor.authorZyluk A.
dc.date.accessioned2020-03-19T09:03:17Z
dc.date.available2020-03-19T09:03:17Z
dc.date.issued2017
dc.identifier.citationKan H.J., Verrijp F.W., Hovius S.E.R., Van Nieuwenhoven C.A., Selles R.W., Amadio P.C., Degreef I., Denkler K., Dias J., Eaton C., Goldfarb C.A., Hentz V., E Horch R., Hurst L., Jerosch-Herold C., Khouri R.K., Lalonde D., Leclercq C., McGrouther D.A., Nanchahal J., Pelissier P., Tonkin M., Werker P.M.N., Wilbrand S., Zyluk A. (2017). Recurrence of Dupuytren's contracture: A consensus-based definition. PLoS ONE 12 (5) : 164849. ScholarBank@NUS Repository. https://doi.org/10.1371/journal.pone.0164849
dc.identifier.issn19326203
dc.identifier.urihttps://scholarbank.nus.edu.sg/handle/10635/165795
dc.description.abstractPurpose: One of the major determinants of Dupyutren disease (DD) treatment efficacy is recurrence of the contracture. Unfortunately, lack of agreement in the literature on what constitutes recurrence makes it nearly impossible to compare the multiple treatments alternatives available today. The aim of this study is to bring an unbiased pool of experts to agree upon what would be considered a recurrence of DD after treatment; and from that consensus establish a much-needed definition for DD recurrence. Methods: To reach an expert consensus on the definition of recurrence we used the Delphi method and invited 43 Dupuytren's research and treatment experts from 10 countries to participate by answering a series of questionnaire rounds. After each round the answers were analyzed and the experts received a feedback report with another questionnaire round to further hone in of the definition. We defined consensus when at least 70% of the experts agreed on a topic. Results: Twenty-one experts agreed to participate in this study. After four consensus rounds, we agreed that DD recurrence should be defined as "more than 20 degrees of contracture recurrence in any treated joint at one year post-treatment compared to six weeks post-treatment ". In addition, "recurrence should be reported individually for every treated joint" and afterwards measurements should be repeated and reported yearly. Conclusion: This study provides the most comprehensive to date definition of what should be considered recurrence of DD. These standardized criteria should allow us to better evaluate the many treatment alternatives. © 2017 Kan et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
dc.publisherPublic Library of Science
dc.sourceUnpaywall 20200320
dc.subjectArticle
dc.subjectclinical practice
dc.subjectconsensus
dc.subjectconsensus development
dc.subjectcontrolled study
dc.subjectDelphi study
dc.subjectDupuytren contracture
dc.subjecthuman
dc.subjectmeasurement
dc.subjectmedical expert
dc.subjectmedical research
dc.subjectoutcome assessment
dc.subjectquestionnaire
dc.subjectrecurrent disease
dc.subjectstandardization
dc.subjecttreatment response
dc.subjectclinical decision making
dc.subjectdisease management
dc.subjectDupuytren contracture
dc.subjectexpert witness
dc.subjectpathology
dc.subjectrecurrent disease
dc.subjecttreatment outcome
dc.subjectClinical Decision-Making
dc.subjectDisease Management
dc.subjectDupuytren Contracture
dc.subjectExpert Testimony
dc.subjectHumans
dc.subjectRecurrence
dc.subjectTreatment Outcome
dc.typeArticle
dc.contributor.departmentDUKE-NUS MEDICAL SCHOOL
dc.description.doi10.1371/journal.pone.0164849
dc.description.sourcetitlePLoS ONE
dc.description.volume12
dc.description.issue5
dc.description.page164849
dc.published.statePublished
Appears in Collections:Staff Publications
Elements

Show simple item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
10_1371_journal_pone_0164849.pdf1.21 MBAdobe PDF

OPEN

NoneView/Download

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.